Beryl Drugs
18.86
-0.12(-0.63%)
Market Cap₹9.54 Cr
PE Ratio632.67
IndustryHealthcare
Company Performance:
1D-0.63%
1M-6.59%
6M-15.20%
1Y-11.66%
5Y+185.33%
View Company Insightsright
More news about Beryl Drugs
06Jan 26
Beryl Drugs Limited Files Q3FY26 Compliance Under Regulation 57(5) Stating Non-Applicability
Beryl Drugs Limited filed its Q3FY26 compliance under Regulation 57(5) with BSE on 6th January, 2026, stating the regulation is not applicable as the company has no non-convertible securities requiring interest, dividend, or principal payments for the quarter ended 31st December, 2025. The filing was authorized by Chairman & Director Sudhir Sethi.
 no imag found
05Jan 26
Beryl Drugs Appoints Directors Under SEBI Regulation 30 Compliance Framework
Beryl Drugs Limited announced board appointments under SEBI Regulation 30 compliance, appointing Mr. Shailendra Pathak (40 years experience, electrical engineering) as Whole Time Director and Mrs. Neha Sarda (CS, 14 years finance experience) as Independent Director, both subject to shareholder approval.
 no imag found
07Aug 25
Beryl Drugs Reports Q1 Net Profit of Rs 2.11 Lakhs Amid Partial Manufacturing Suspension
Beryl Drugs Limited announced a turnaround to profitability for Q1 ended June 30, with a net profit of Rs 2.11 lakhs compared to a net loss of Rs 36.79 lakhs in the previous year's Q1. Revenue from operations increased to Rs 483.58 lakhs from Rs 287.73 lakhs. The company's manufacturing facility is partially under suspension and upgradation, impacting the turnover for the entire quarter. Despite this, Beryl Drugs improved its financial performance significantly. Total expenses decreased to Rs 476.61 lakhs, and earnings per share stood at Rs 0.04.
 no imag found
Beryl Drugs
18.86
-0.12
(-0.63%)
1 Year Returns:-11.66%
Industry Peers
Sun Pharmaceutical
1,693.60
(-2.02%)
Divis Laboratories
5,856.50
(-0.85%)
Torrent Pharmaceuticals
3,987.20
(-3.02%)
Lupin
2,274.50
(-0.02%)
Dr Reddys Laboratories
1,217.30
(+0.64%)
Cipla
1,192.40
(-0.29%)
Zydus Life Science
864.25
(+0.12%)
Mankind Pharma
1,998.50
(-0.14%)
Aurobindo Pharma
1,333.70
(-0.63%)
Alkem Laboratories
5,258.00
(+0.26%)